Groundbreaking discovery reveals how UHRF1 phase separation drives prostate cancer progression through epigenetic mechanisms.
Discover how AKR1C3 and AR-V7 work together to create treatment resistance in advanced prostate cancer and the emerging therapeutic strategies to overcome this challenge.